Shree Ganesh Biotech India Ltd (SHREEGANES) Share Price & Fundamentals

What we do

Shree Ganesh Biotech India Ltd produces, processes, and markets high-quality hybrid seeds for crops like corn, sunflower, cotton, paddy, and grain sorghum.

Founded in

1,982

Market share

A significant player in India's hybrid seed market with growing revenue and diversified crop coverage.

Problem solved

Provides high-yield hybrid seeds to boost crop productivity and support farmers with quality agricultural inputs.

Top clients or who we serve

Primarily serves Indian farmers and agricultural businesses in seed distribution and trading (B2B and B2C).

Key management

Mr. Aman Pravinkumar Patel (Whole Time Director), Mr. Kishan Nityanand Naidu (Director)

Our journey and innovations

Founded in 1982, merged with Shree Ganesh Bio-Tech Pvt. Ltd in 2010; expanded into hybrid seed production and marketing.

Where we operate

Operations primarily in India, with a focus on regional agricultural markets.

Top products or what we offer

Hybrid seeds for corn, sunflower, cotton, paddy, grain sorghum.

Top brands

-

Raw materials needed

High-quality seed genetic materials for hybrid seed production.

Raw materials supplier

-

Recurring vs cyclical contribution

Revenue mainly from cyclical agricultural seed sales aligned with crop seasons.

Our industry position

Growing presence in hybrid seed market, enhancing market share with diversified crop portfolio.

Financial highlights

FY 2024-25 revenue Rs 229.6 crores; net profit Rs 2.78 crores; steady income growth year-over-year.

Geographical revenue split

-

Order book

-

Whats driving growth

Increasing demand for hybrid seeds and adoption of improved agricultural practices drive growth.

Our future plans

Focus on expanding hybrid seed varieties and strengthening distribution networks across India.

Our green promise

-

Our people and values

Emphasizes employee harmony and equal opportunities; values human capital as key asset.

Key challenges ahead

Regulatory compliance, competition, and agricultural market fluctuations.

Interesting facts

Underwent significant amalgamation in 2010 to consolidate biotech seed business.

Risks and strategy

Mitigates risks with internal controls and focuses on innovation and market expansion.